Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (121-130 of 219) with videos related to

Pageof 22
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 1, 1994
Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertensionK Huber, R Beckmann, H Frank, et al.
Thrombosis Research|June 15, 1992
Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancerK Okajima, I Kohno, J Tsuruta, et al.
The Journal of Biological Chemistry|January 28, 1994
The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitorD Seiffert, G Ciambrone, N V Wagner, et al.
Blood|March 1, 1993
Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cellsG Christ, D Seiffert, P Hufnagl, et al.
Genomics|January 8, 1999
Localization of the human I-kappaB kinase-beta (IKBKB) to chromosome 8p11.2 by fluorescence in situ hybridization and radiation hybrid mappingP F Ambros, J Schmid, S Rumpler, et al.
Thrombosis Research|September 15, 1989
Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatmentK Huber, I Resch, D Rosc, et al.
Wiener Klinische Wochenschrift|March 1, 1985
[Use of monoclonal antibodies in the diagnosis of fibrinolysis]J Wojta, C Korninger, J Kirchheimer, et al.
Pflugers Archiv : European Journal of Physiology|May 1, 1995
High precision measurement of electrical resistance across endothelial cell monolayersW Tschugguel, Z Zhegu, L Gajdzik, et al.
Agents and Actions. Supplements|January 1, 1992
Possible identity of kallikrein binding protein with protein C inhibitorS Ecke, M Geiger, I Resch, et al.
Wiener Klinische Wochenschrift|September 14, 1984
[Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer]H Pflüger, J Kirchheimer, P Ritschl, et al.
Pageof 22

Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
American Journal of Respiratory and Critical Care Medicine|October 1, 1994
Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertensionK Huber, R Beckmann, H Frank, et al.
Thrombosis Research|June 15, 1992
Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancerK Okajima, I Kohno, J Tsuruta, et al.
The Journal of Biological Chemistry|January 28, 1994
The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitorD Seiffert, G Ciambrone, N V Wagner, et al.
Blood|March 1, 1993
Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cellsG Christ, D Seiffert, P Hufnagl, et al.
Genomics|January 8, 1999
Localization of the human I-kappaB kinase-beta (IKBKB) to chromosome 8p11.2 by fluorescence in situ hybridization and radiation hybrid mappingP F Ambros, J Schmid, S Rumpler, et al.
Thrombosis Research|September 15, 1989
Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatmentK Huber, I Resch, D Rosc, et al.
Wiener Klinische Wochenschrift|March 1, 1985
[Use of monoclonal antibodies in the diagnosis of fibrinolysis]J Wojta, C Korninger, J Kirchheimer, et al.
Pflugers Archiv : European Journal of Physiology|May 1, 1995
High precision measurement of electrical resistance across endothelial cell monolayersW Tschugguel, Z Zhegu, L Gajdzik, et al.
Agents and Actions. Supplements|January 1, 1992
Possible identity of kallikrein binding protein with protein C inhibitorS Ecke, M Geiger, I Resch, et al.
Wiener Klinische Wochenschrift|September 14, 1984
[Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer]H Pflüger, J Kirchheimer, P Ritschl, et al.
Pageof 22